Shilpa Medicare Limited — Credit Ratings, 02-07-2025: Credit Rating- Revision

India Ratings & Research has affirmed Shilpa Medicare Limited’s credit rating at IND A+ while revising the outlook to Positive from Stable, reflecting improved financial health and operational performance. Similarly, Shilpa Pharma Lifesciences Limited’s ratings were affirmed at IND A+ with an upgraded outlook to Positive, supported by a reduction in working capital limits and non-convertible debentures, as well as the assignment of a proposed INR 75 Cr term loan. The positive outlook across both entities signals enhanced liquidity and prudent debt management, which is likely to lower their cost of borrowing and strengthen investor confidence, providing them greater strategic flexibility going forward.